Table 4 Distant relapse-free survival and progression free survival
Arm A (BVZ + CAPE + RT) | Arm B (CAPE + RT) | |
|---|---|---|
Distant relapse-free survival | 44 patients | 46 patients |
No of patients with event | 11 (25.00%) | 10 (21.74%) |
No of censored patients | 33 (75.00%) | 36 (78.26%) |
Percent Survival (%, 95 CI) | ||
36 Time (months) | 81.05 (65.65, 90.04) | 80.43 (65.77, 89.30) |
60 Time (months) | 76.20 (60.27, 86.43) | 78.26 (63.36, 87.66) |
Kaplan-Meier model | ||
P-value (Log-rank) | 0.6923 | |
Cox Model | Hazard ratio (95% CI) | Cox Model P-value |
Arm A (BVZ + CAPE+RT) vs Arm B (CAPE+RT) | 1.1887 (0.5047, 2.8000) | 0.6924 |
Disease free survival | ||
No of patients with event | 15 (34.09%) | 15 (32.61%) |
Earliest contributing event: | ||
Distant metastases | 11 | 10 |
Second tumor | 1 | 4 |
Death | 3 | 1 |
No of censored patients | 29 (65.91%) | 31 (67.39%) |
Lab | ||
Median (95% CI) | NA (62.76, NA) | NA (64.13, NA) |
25th–75th percentile | 34.67 - NA | 19.22 - NA |
Percent Survival (%, 95 CI) | ||
36 months | 75.00 (59.42, 85.30) | 71.74 (56.36, 82.50) |
60 months | 68.18 (52.27, 79.76) | 69.57 (54.09, 80.71) |
Kaplan-Meier model | ||
P-value (Log-rank) | 0.9820 | |
Cox Model | Hazard ratio (95% CI) | Cox Model P-value |
Arm A (BVZ + CAPE+RT) vs Arm B (CAPE+RT) | 1.0083 (0.4927, 2.0635) | 0.9820 |